Search clinical trials for: Mycophenolate mofetil

Total 880 results

National Institute of Diabetes and Digestive and...

Terminated

A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . (ICCRN RCT2)

Interstitial Cystitis | Painful Bladder Syndrome

United States, Canada
University of Giessen
Novartis; Hoffmann-La Roche; Astellas Pharma Inc; Heidelberg University

Completed

Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

Polyomavirus Infections

Germany
Novartis Pharmaceuticals

Completed

Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance

Renal Transplantation

United States
Nanjing University School of Medicine

Completed

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN

Nephritis | Henoch-Schoenlein Purpura

China
Children's Hospital of Fudan University
Shanghai Children's Hospital; Shanghai Children's Medical Center; Xinhua Hospital...

Withdrawn

Randomized Trial Evaluating Mycophenolate Mofetil in Children With Nephrotic Syndrome After Rituximab Treatment

Steroid-Dependent Nephrotic Syndrome | Frequently Relapsing Nephrotic Syndrome

China
Nanjing University School of Medicine

Completed

MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis

Vasculitis | Anti-Neutrophil Cytoplasmic Antibody

China
Teva Branded Pharmaceutical Products R&D, Inc.
Parexel

Terminated

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Stable Renal Transplant Recipients
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

Healthy Volunteers

India
Fred Hutchinson Cancer Center
University of Washington

Completed

MMF for HIV Reservoir Reduction

Human Immunodeficiency Virus I Infection

United States
Samsung Medical Center

Unknown

Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept (NODAT)

Diabetes

Korea, Republic of
Hoffmann-La Roche
Aspreva Pharmaceuticals

Completed

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

Pemphigus Vulgaris (PV)

Turkey, Switzerland, United States, Germany, United Kingdom, Ukraine, Israel, Canada
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients (My-Rept_KT_P4)

Kidney Transplantation

Korea, Republic of
Asan Medical Center

Unknown

TO Compare the Triple Drug Therapy and Dual Therapy . (OPTIMUS-A)

HEPATITIS

Korea, Republic of
Lingyun Sun

Unknown

Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)

Lupus Nephritis

China
University of Washington
Genentech, Inc.

Completed

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Diabetic Nephropathies | Kidney Failure, Chronic | Glomerulonephritis, IGA | Hypertension, Renal
Ajou University School of Medicine

Completed

Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

Disorder Related to Renal Transplantation

Korea, Republic of
Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Completed

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) (AUC-MPA)

Renal Transplantation

Brazil
The Children's Hospital of Zhejiang University...
Peking University First Hospital; Tongji Hospital; Shandong Provincial Hospital; Children's Hospital of Fudan University and other collaborators

Completed

Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome (STAMP)

Nephrotic Syndrome in Children

China
Hoffmann-La Roche
Genentech, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)

Pemphigus Vulgaris

United States, Spain, Israel, Australia, France, Argentina, Canada, Turkey, Germany, Brazil, Italy, Ukraine
Centre Hospitalier Universitaire, Amiens
Novartis

Unknown

Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME) (CIME)

Kidney Failure

France
Shanghai Chest Hospital

Recruiting

Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib (AUTOMAN)

Metastatic Cancer | Adenocarcinoma of Lung | Non-Small Cell Lung Cancer With EGFR Mutation | Locally Advanced Solid Tumor

China
University of Pennsylvania
Novartis Pharmaceuticals

Terminated

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Transplants and Implants

United States
Novartis

Completed

Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil

Maintenance Kidney Transplant

Switzerland
Astellas Institute for Regenerative Medicine

Withdrawn

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD (PORTRAY)

Age-Related Macular Degeneration

United States
University of Minnesota
Wyeth is now a wholly owned subsidiary of Pfizer; Roche Pharma AG; Genzyme, a...

Completed

Calcineurin Inhibitor Sparing After Kidney Transplantation (CNI-Sparing)

CNI Side Effects

United States
Oklahoma Medical Research Foundation
NYU Langone Health

Completed

Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis

Arthritis | Systemic Lupus Erythematosus

United States
Hospital Vall d'Hebron

Completed

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Hepatitis C Recurrence After Liver Transplant

Spain
Novartis Pharmaceuticals

Completed

Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation

Renal Transplant

United Kingdom
Rigshospitalet, Denmark

Completed

Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Autoimmune Hepatitis

Denmark
Medical University of South Carolina
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Sirolimus Conversions in African-American Renal Transplant Recipients

Absence; Kidney

United States
Children's Hospital of Chongqing Medical University

Recruiting

Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome

Nephrotic Syndrome in Children

China
Peking Union Medical College Hospital

Recruiting

Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement

Autoimmune Diseases

China
Peking Union Medical College Hospital

Unknown

Study of Treatment Response on IgG4 Related Disease (IgG4RD)

Autoimmune Disease

China
University of Florida
Hoffmann-La Roche

Completed

Pilot Trial for Implementation of a MPA PK Monitoring Strategy (MPA)

Transplant, Kidney

United States
Second Xiangya Hospital of Central South University

Unknown

Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.

IgA Nephropathy

China
Nantes University Hospital

Completed

A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant

Renal Transplantation

France
University of Miami
Novartis Pharmaceuticals

Completed

Myfortic vs. Cellcept in Kidney Transplant Recipients

End Stage Renal Disease

United States
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial (TN02)

Diabetes Mellitus, Type 1

United States, Canada
Seoul National University Hospital
National Institute of Food and Drug Safety Evaluation (Republic of Korea)

Recruiting

Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation

Korea, Republic of
Chulalongkorn University
Berlin Pharmaceutical Industry

Terminated

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

Lupus Nephritis

Thailand
Columbia University

Completed

Study of CellCept for Advanced Pancreatic Cancer

Pancreatic Cancer

United States
King Faisal Specialist Hospital & Research Center

Unknown

Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Saudi Arabia
Children's Hospital Medical Center, Cincinnati

Withdrawn

Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis (PRUNE)

Lupus Nephritis
Minia University

Completed

Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel

Tinea

Egypt
Emory University

Terminated

Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept

Cardiac Transplantation

United States
University Hospital, Limoges
Hoffmann-La Roche

Unknown

Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients

Kidney Transplant Recipients

France
Novartis Pharmaceuticals

Terminated

A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms

Renal Transplantation

United States
University of California, San Francisco

Withdrawn

Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk (STIFLE-RISK)

Infection | Transplant;Failure,Kidney

United States
Roxane Laboratories

Completed

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Prophylaxis of Organ Rejection

United States

Search clinical trials for: Mycophenolate mofetil

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations